Found: 121
Select item for more details and to access through your institution.
Response to Guo et al.'s Letter to the Editor.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Rank-based two-sample tests for paired data with missing values.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03154-6
- By:
- Publication type:
- Article
The Pharmacokinetics and Serum and Urine Bactericidal Activity of Ciprofloxacin.
- Published in:
- 1985
- By:
- Publication type:
- Other
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 1, p. 359, doi. 10.1172/JCI60202
- By:
- Publication type:
- Article
Mucosal effects of tenofovir 1% gel.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.04525.001
- By:
- Publication type:
- Article
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders.
- Published in:
- Nature Medicine, 2015, v. 21, n. 10, p. 1139, doi. 10.1038/nm.3932
- By:
- Publication type:
- Article
One shot forward for HIV prevention.
- Published in:
- Nature Medicine, 2014, v. 20, n. 3, p. 241, doi. 10.1038/nm.3503
- By:
- Publication type:
- Article
Corrigendum: Protective HIV-specific CD8<sup>+</sup> T cells evade T<sub>reg</sub> cell suppression.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Protective HIV-specific CD8<sup>+</sup> T cells evade T<sub>reg</sub> cell suppression.
- Published in:
- Nature Medicine, 2011, v. 17, n. 8, p. 989, doi. 10.1038/nm.2422
- By:
- Publication type:
- Article
HIV vaccines: mosaic approach to virus diversity.
- Published in:
- Nature Medicine, 2010, v. 16, n. 3, p. 268, doi. 10.1038/nm0310-268
- By:
- Publication type:
- Article
Repeat-Region Polymorphisms in the Gene for the Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin- Related Molecule: Effects on HIV-1 Susceptibility.
- Published in:
- Journal of Infectious Diseases, 2006, v. 193, n. 5, p. 698, doi. 10.1086/499820
- By:
- Publication type:
- Article
High-Dose Recombinant Canarypox Vaccine Expressing HIV-1 Protein, in Seronegative Human Subjects.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 7, p. 1249
- By:
- Publication type:
- Article
Demographic Factors That Influence the Neutralizing Antibody Response in Recipients of Recombinant HIV-1 gp120 Vaccines.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 11, p. 1962
- By:
- Publication type:
- Article
Analysis of Genetic Polymorphisms in CCR5, CCR2, Stromal Cell--Derived Factor--1, RANTES, and Dendritic Cell--Specific Intercellular Adhesion Molecule--3--Grabbing Nonintegrin in Seronegative Individuals Repeatedly Exposed to HIV-1.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 6, p. 1055, doi. 10.1086/423209
- By:
- Publication type:
- Article
Breakthrough Infections during Phase 1 and 2 Prime-Boost HIV-1 Vaccine Trials with Canarypox Vectors (ALVAC) and Booster Dose of Recombinant gp120 or gp160.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 5, p. 903, doi. 10.1086/423284
- By:
- Publication type:
- Article
Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV-1 Genes or the Gene for Rabies Virus G Protein.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 7, p. 1221
- By:
- Publication type:
- Article
Association of T Cell Proliferative Responses and Phenotype with Virus Control in Chronic Progressive HIV-1 Disease.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 3, p. 515, doi. 10.1086/381038
- By:
- Publication type:
- Article
Moving to Human Immunodeficiency Virus Type 1 Vaccine Efficacy Trials: Defining T Cell Responses As Potential Correlates of Immunity.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 2, p. 226, doi. 10.1086/367702
- By:
- Publication type:
- Article
Human Immunodeficiency Virus-Specific and CD3-Redirected Cytotoxic T Lymphocyte Activity in the Human Female Reproductive Tract: Lack of Correlation between Mucosa and Peripheral Blood.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 6, p. 977, doi. 10.1086/319253
- By:
- Publication type:
- Article
Alterations in T Cell Phenotype and Human Immunodeficiency Virus Type 1-Specific Cytotoxicity after Potent Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 5, p. 722, doi. 10.1086/318816
- By:
- Publication type:
- Article
Two Double-Blinded, Randomized, Comparative Trials of 4 Human Immunodeficiency Virus Type 1...
- Published in:
- Journal of Infectious Diseases, 2000, v. 182, n. 5, p. 1357
- By:
- Publication type:
- Article
Effect of Combination Antiretroviral Therapy on T-Cell Immunity in Acute Human Immunodeficiency...
- Published in:
- Journal of Infectious Diseases, 2000, v. 181, n. 1, p. 121, doi. 10.1086/315202
- By:
- Publication type:
- Article
A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8[sup+] Cytotoxic T Lymphocyte Responses in Seronegative Volunteers.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 2, doi. 10.1086/314895
- By:
- Publication type:
- Article
Early and Persistent Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Helper Dysfunction in Blood and Lymph Nodes following Acute HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 2, doi. 10.1086/314868
- By:
- Publication type:
- Article
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 5, p. 1230
- By:
- Publication type:
- Article
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 310, doi. 10.1086/514209
- By:
- Publication type:
- Article
Cytotoxic T Cell and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Envelope with a Combination Vaccine Regimen.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 301, doi. 10.1086/514202
- By:
- Publication type:
- Article
Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus-Uninfected Recipients of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 4, p. 764
- By:
- Publication type:
- Article
Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with ⩾400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 2, p. 247
- By:
- Publication type:
- Article
Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 340
- By:
- Publication type:
- Article
Determinants Of Antibody Response After Recombinant Gp160 Boosting In Vaccinia-Naive Volunteers Primed With Gp160-Recombinant Vaccinia Virus.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 4, p. 782
- By:
- Publication type:
- Article
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Persistent serum protein signatures define an inflammatory subcategory of long COVID.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38682-4
- By:
- Publication type:
- Article
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0136626
- By:
- Publication type:
- Article
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0108631
- By:
- Publication type:
- Article
The Inner Foreskin of Healthy Males at Risk of HIV Infection Harbors Epithelial CD4+ CCR5+ Cells and Has Features of an Inflamed Epidermal Barrier.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0108954
- By:
- Publication type:
- Article
HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101863
- By:
- Publication type:
- Article
MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043396
- By:
- Publication type:
- Article
A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0042163
- By:
- Publication type:
- Article
Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0033969
- By:
- Publication type:
- Article
Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028632
- By:
- Publication type:
- Article
Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024517
- By:
- Publication type:
- Article
A Phase IIA Randomized Clinical Trial of a Multiclade HIV- 1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204).
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0021225
- By:
- Publication type:
- Article
Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0020479
- By:
- Publication type:
- Article
Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018526
- By:
- Publication type:
- Article
Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0015639
- By:
- Publication type:
- Article
Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0013916
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054).
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013579
- By:
- Publication type:
- Article